# A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

> **NCT03062618** · PHASE1 · COMPLETED · sponsor: **PRCL Research Inc.** · enrollment: 50 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** PRCL-02
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03062618
- **Lead sponsor:** PRCL Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2018-02-08
- **Final completion:** 2018-02-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062618, "A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03062618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*